LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 86.03 | 21.74 | 10902 | 6155 | 1.7711 | 1.1454 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.00 | 21.74 | 1 | 6081 | 0.0002 | -0.3153 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.00 | 21.74 | 12153 | 6081 | 1.9984 | 1.1778 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.00 | 21.74 | 98 | 6081 | 0.0161 | 0.2035 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 88.00 | 21.74 | 11092 | 6081 | 1.8239 | 1.1535 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.97 | 21.74 | 1 | 6084 | 0.0002 | -0.3153 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.97 | 21.74 | 12369 | 6084 | 2.0329 | 1.1824 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.97 | 21.74 | 81 | 6084 | 0.0133 | 0.1756 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 89.97 | 21.74 | 11374 | 6084 | 1.8694 | 1.1600 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.94 | 21.74 | 1 | 6121 | 0.0002 | -0.3150 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.94 | 21.74 | 12501 | 6121 | 2.0420 | 1.1834 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.94 | 21.74 | 91 | 6121 | 0.0149 | 0.1924 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 91.94 | 21.74 | 11676 | 6121 | 1.9073 | 1.1652 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 93.92 | 21.74 | 1 | 6070 | 0.0002 | -0.3154 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 93.92 | 21.74 | 12493 | 6070 | 2.0582 | 1.1858 | MN20160310_N01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 93.92 | 21.74 | 94 | 6070 | 0.0155 | 0.1975 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 93.92 | 21.74 | 11925 | 6070 | 1.9646 | 1.1733 | MN20160310_N01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.24 | 21.74 | 339 | 183 | 1.8467 | 1.4411 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 2.24 | 21.74 | 533 | 183 | 2.9035 | 1.8277 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.24 | 21.74 | 622 | 317 | 1.9573 | 1.3790 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.24 | 21.74 | 1 | 317 | 0.0031 | -0.5487 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 4.24 | 21.74 | 864 | 317 | 2.7188 | 1.5899 | MN20160310_N01 | J07 |